Immediate Impact
3 by Nobel laureates 5 from Science/Nature 71 standout
Citing Papers
PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
2024 Standout
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Works of Eileen Regan being referenced
A prospective, phase 1/2 study of everolimus and temozolomide in patients with advanced pancreatic neuroendocrine tumor
2013
Multicenter Phase II Study of Tivozanib (AV-951) and Everolimus (RAD001) for Patients With Refractory, Metastatic Colorectal Cancer
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Eileen Regan | 608 | 233 | 355 | 251 | 34 | 889 | |
| Krzysztof Jeziorski | 463 | 255 | 264 | 130 | 24 | 791 | |
| D.G. Haller | 531 | 285 | 170 | 122 | 28 | 791 | |
| Siobhan Nicholson | 531 | 332 | 253 | 67 | 33 | 939 | |
| Mona Fouad | 629 | 273 | 178 | 74 | 32 | 879 | |
| Robert F. Marschke | 576 | 273 | 257 | 157 | 39 | 857 | |
| Emmanuel Mitry | 799 | 196 | 417 | 217 | 19 | 1.1k | |
| Iris Tischoff | 393 | 157 | 184 | 85 | 49 | 1.0k | |
| Harry H. Miller | 435 | 140 | 288 | 91 | 26 | 944 | |
| D Atlan | 578 | 195 | 90 | 116 | 24 | 964 | |
| Paola Aimone | 521 | 331 | 208 | 150 | 43 | 1.1k |
All Works
Loading papers...